“…However, other factors, such as the presence of a different formulation or contraindication, were regarded as off-label or unlicenced by different authors. Only 12 papers [19,20,28,30,32,33,35,38,39,46,49,51] accepted the definition of off-label and/or unlicenced drugs proposed by Turner et al [19]. Unlike the latter [19], some authors viewed contraindicated drugs for paediatric use as unlicenced [22,27,34,43,47,48] and drugs with a formulation other than that which had been approved as offlabel [21-25, 27, 34, 40, 41, 43, 47, 50].…”